News and Trends 11 Aug 2020
How European Startups Have Advanced Cancer T-Cell Therapy in 2020
With the help of a huge €66M Series A round last week, the German startup T-knife is developing cancer T-cell…
Medigene
- Latest Posts
Best in Biotech 4 Nov 2019
Top 10 Biotech Companies Leaving a Mark in Munich
These are the top 10 biotech companies in Munich, one of the hottest hubs for the biotechnology industry. One of…
News and Trends 14 May 2018
German Biotech Expands Oncology Deal with Bluebird bio to $1.5Bn
Medigene and bluebird bio are increasing the number of cancer targets against which to develop TCR candidates, raising their already huge…
Best in Biotech 8 Mar 2018
Say Hello to the Top 14 Entrepreneurial Women in European Biotech
Today, March 8, is international women's day. To celebrate the achievements of women we're revisiting our list of the women…
ADVERTISEMENT
Startup Scout 2 Jun 2017
This French Biotech Wants to Reinvent DC-based Immunotherapies
This week we had the chance to visit both Grenoble and Liège, where the French-Belgian biotech hybrid PDC*line Pharma has…
Interview 20 Apr 2017
Which EU Immuno-Oncology Company are you Cheering for?
Immuno-oncology represents a huge breakthrough towards the search for a cancer cure. Biotechs all around Europe are developing innovative ways…
Infographics 13 Feb 2017
Infographic: What’s in Europe’s Immuno-oncology Pipeline?
While some might accuse the field of being over-hyped, immuno-oncology continues to attract attention and investment for its potential to cure cancer.…
News and Trends 26 Dec 2016
The Largest Deals, Fundraising and Exits of 2016 in European Biotech
Curious about which technologies have attracted the most cash in biotech finance this year? Here's a list of the most impressive cash…
News and Trends 25 Nov 2016
Stories We Didn’t Cover: Malaria Vaccine Money, Diabetes FDA Approvals
Try as we might, we can't cover all the biotech news out there. During the week, we only pick the…
News and Trends 29 Sep 2016
Titans in Gene Therapy and TCRs make a Massive Deal
Medigene has licensed a few candidates from its TCR platform to one of the Boston 'it' biotechs in a deal…
News and Trends 30 Jun 2016
Key German Hospital to start a Phase I trial in TCR Cell Therapy
Medigene will make its clinical debut in TCR, in a collaboration with the Max Delbrück Centre and the Charité Hospital…
Best in Biotech 22 Jun 2016
11 Biotech Leaders you should meet in Munich
I guess you've read some of our tops lately (VCs, Paris, Unicorns). Those were mainly about specific companies or regions.…
News and Trends 21 Dec 2015
Here’s my Chat with the CBO of Immunocore, the Only EU Biotech to have ever raised €300M in one Round
Last Thursday at Genesis in London, I had the chance to meet with Eva-Lotta Allan, CBO of Immunocore (and previously from…
News and Trends 3 Nov 2015
Exclusive from BIO-Europe 2015: Interview of Peter Llewellyn-Davies, CFO at Medigene, Munich-based Immunotherapy Biotech
This is the third interview we publish from BIO (yes, we are working hard). It comes after the interview of Simon…
News and Trends 22 Jul 2015
Adaptimmune’s TCR Therapy Proves its Superiority over its Immuno-oncology Competitors
Adaptimmune Therapeutics, an oxford-based company focusing on the use of T-cell therapies to treat cancer, announced today that data from its…
